MEI Pharma, Inc. Banner Image

MEI Pharma, Inc.

  • Ticker MEIP
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
MEI Pharma, Inc. Logo Image
  • 51-200 Employees
  • Based in San Diego, California
MEI Pharma, Inc. (NASDAQ: MEIP) is a late-stage pharmaceutical company focused on developing potential new therapies for cancer. MEI Pharma's portfolio of drug candidates contains four clinical-stage assets, including zandelisib, currently in an ongoing Phase 2 clinical trial which may support an accelerated approval marketing application with the U.S. Food and Drug Administration. EachMore of MEI Pharma's pipeline candidates leverages a different mechanism of action with the objective of developing therapeutic options that are: (1) differentiated, (2) address unmet medical needs and (3) deliver improved benefit to patients either as standalone treatments or in combination with other therapeutic options.
4.8 / 5.0 (186)

MEI Pharma, Inc. reports have an aggregate usefulness score of 4.8 based on 186 reviews.

MEI Pharma, Inc.

Most Recent Annual Report

MEI Pharma, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

MEI Pharma, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!